Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06581796
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-30
Brief Title:
Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Changes in Pepsinogen-1 Serum Levels in Patients Diagnosed With Hyperemesis Gravidarum
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the investigators planned to investigate serum pepsinogen-1 levels in women with hyperemesis gravidarum and uncomplicated pregnancy
The benefit the investigators expect from the study is to determine whether there is a difference in serum pepsinogen-1 levels in pregnant women with hyperemesis gravidarum compared to normal pregnant women It should demonstrate the importance of pepsinogen-1 in predicting the pathogenesis prognosis perinatal outcome and severity of hyperemesis gravidarum The study poses no risk to the pregnant woman or the fetus
The benefit the investigators expect from the study is to determine whether there is a difference in serum pepsinogen-1 levels in pregnant women with hyperemesis gravidarum compared to normal pregnant women It should demonstrate the importance of pepsinogen-1 in predicting the pathogenesis prognosis perinatal outcome and severity of hyperemesis gravidarum The study poses no risk to the pregnant woman or the fetus
Detailed Description:
The study will enroll pregnant women in the first trimester with maternal age between 21 and 35 years who were diagnosed with hyperemesis gravidarum and had no fetal congenital or chromosomal abnormalities and who were admitted to the perinatology outpatient clinic of Etlik City Hospital The investigators will include 40 cases with no signs and diagnosis of systemic maternal disease and no chronic drug use as a case group and 40 healthy pregnant women matched for age gestational week and body mass index as a control group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None